Olivari Z, Piccolo E
Divisione Cardiologica, Ospedale Cà Foncello, Treviso.
Ital Heart J Suppl. 2001 Jan;2(1):10-1.
In the last few years we have witnessed a substantial growth in the number of catheterization laboratories, especially in the northern regions of Italy, a phenomenon which has met some controversy and has been discussed in a Symposium at the ANMCO National Conference (Florence, May 20-23, 2000). The controversy is essentially between those who believe in the implementation of catheterization laboratories in all cardiology units equipped with a cardiological intensive care unit (and the creation of a functional network with the tutorial centers) and those who refer to the existing guidelines, standards and VRQ which envisage a geographical distribution of laboratories on the basis of a balance between needs of the population and the minimum quantity of procedures performed by each center in order to guarantee the best quality and cost-effectiveness. The aim of the Symposium was to clarify whether the two "innovations" of these last few years, namely the introduction of new portable radiological equipment on the one hand and the effectiveness of primary angioplasty in the treatment of acute myocardial infarction on the other, may influence the redefinition of criteria regarding the distribution of laboratories, taking into account as well the expansion of indications for coronary angioplasty and coronary angiography. After a lively discussion, the proceedings can be summed up as follows: no agreement was reached regarding the role of portable radiological equipment in the decisional process regarding the setting up of a new catheterization laboratory; primary angioplasty should be carried out in centers with an adequate volume of activity and a functioning inter-hospital organizational structure for this demanding activity; otherwise it does not offer any advantages over fibrinolytic therapy; the proposal of a new organizational model is based on the creation of transverse inter-hospital cardiology departments, the size of which is based on the overall size of the user population, with interventional laboratories distributed in the reference hospitals and diagnostic laboratories in hospitals equipped with a cardiologic intensive care unit (where there is a sufficiently large user population to guarantee at least the minimum number of procedures envisaged by the standards); both parts should work in close cooperation. On this last point there was a contrasting opinion and it was not possible to reach a consensus. The Scientific Societies should formally express their views on this controversial topic, so that guidelines, standards and VRQ can be updated rapidly. The latter should constitute the reference for the procedures of accreditation to which all laboratories and cardiology departments are subjected to, and it is likely that this will be the best way to overcome the present controversy.
在过去几年里,我们目睹了导管实验室数量的大幅增长,尤其是在意大利北部地区,这一现象引发了一些争议,并在意大利心脏病学会全国会议(2000年5月20 - 23日,佛罗伦萨)的一次研讨会上进行了讨论。争议主要存在于两派之间,一派主张在所有配备心脏重症监护病房的心脏病科设立导管实验室(并与辅导中心建立功能网络),另一派则依据现有的指南、标准和VRQ,这些规定基于人口需求与每个中心为保证最佳质量和成本效益而执行的最低手术量之间的平衡来规划实验室的地理分布。研讨会的目的是弄清楚过去几年的两项“创新”,一方面是新型便携式放射设备的引入,另一方面是直接冠状动脉介入治疗在急性心肌梗死治疗中的有效性,是否会影响实验室分布标准的重新定义,同时还要考虑冠状动脉介入治疗和冠状动脉造影适应证的扩大。经过热烈讨论,会议结果可总结如下:在关于设立新导管实验室的决策过程中,便携式放射设备的作用未达成一致意见;直接冠状动脉介入治疗应在具备足够手术量以及针对这项高要求活动的有效医院间组织结构的中心进行;否则,它相较于溶栓治疗并无优势;新组织模式的提议基于创建跨医院横向心脏病科,其规模依据用户总体规模确定,介入实验室分布在参考医院,诊断实验室设在配备心脏重症监护病房的医院(那里有足够多的用户群体以保证至少达到标准规定的最低手术量);两部分应密切合作。关于最后这一点存在不同意见,未能达成共识。科学学会应就这一有争议的话题正式发表意见,以便迅速更新指南、标准和VRQ。后者应成为所有实验室和心脏病科都需遵循的认证程序的参考依据,这很可能是克服当前争议的最佳方式。